Open Access

[Corrigendum] Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines

  • Authors:
    • Toni Ibrahim
    • Chiara Liverani
    • Laura Mercatali
    • Emanuele Sacanna
    • Michele Zanoni
    • Francesco Fabbri
    • Wainer Zoli
    • Dino Amadori
  • View Affiliations

  • Published online on: July 6, 2016     https://doi.org/10.3892/ijo.2016.3613
  • Pages: 1260-1260
  • Copyright: © Ibrahim et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

September 2016
Volume 49 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Ibrahim, T., Liverani, C., Mercatali, L., Sacanna, E., Zanoni, M., Fabbri, F. ... Amadori, D. (2016). [Corrigendum] Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines. International Journal of Oncology, 49, 1260-1260. https://doi.org/10.3892/ijo.2016.3613
MLA
Ibrahim, T., Liverani, C., Mercatali, L., Sacanna, E., Zanoni, M., Fabbri, F., Zoli, W., Amadori, D."[Corrigendum] Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines". International Journal of Oncology 49.3 (2016): 1260-1260.
Chicago
Ibrahim, T., Liverani, C., Mercatali, L., Sacanna, E., Zanoni, M., Fabbri, F., Zoli, W., Amadori, D."[Corrigendum] Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines". International Journal of Oncology 49, no. 3 (2016): 1260-1260. https://doi.org/10.3892/ijo.2016.3613